HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Xu Selected Research

Cefonicid (Monocid)

9/2017Separation and characterization of unknown impurities in cefonicid sodium by trap-free two-dimensional liquid chromatography combined with ion trap time-of-flight mass spectrometry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Xu Research Topics

Disease

93Neoplasms (Cancer)
07/2022 - 02/2007
24Insulin Resistance
03/2022 - 03/2011
21Allergic Rhinitis
09/2022 - 03/2011
19Inflammation (Inflammations)
10/2022 - 12/2005
18Stomach Neoplasms (Stomach Cancer)
01/2020 - 02/2007
17Type 2 Diabetes Mellitus (MODY)
05/2022 - 04/2011
17Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2013
17Hypertension (High Blood Pressure)
01/2022 - 09/2009
16Obesity
01/2022 - 02/2012
14Non-alcoholic Fatty Liver Disease
10/2022 - 01/2013
13Melanoma (Melanoma, Malignant)
01/2022 - 05/2016
13Prediabetic State (Prediabetes)
01/2022 - 06/2013
13Retinopathy of Prematurity (Retrolental Fibroplasia)
01/2022 - 06/2013
12Atherosclerosis
01/2022 - 01/2013
11Pneumonia (Pneumonitis)
04/2022 - 06/2006
11Hypoxia (Hypoxemia)
03/2022 - 02/2008
11Infections
01/2022 - 06/2003
11COVID-19
10/2021 - 01/2020
10Abdominal Obesity
11/2019 - 05/2011
9Neoplasm Metastasis (Metastasis)
01/2021 - 02/2007
9Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 03/2011
8Fibrosis (Cirrhosis)
11/2021 - 05/2003
8Nasopharyngeal Carcinoma
01/2021 - 12/2007
8Breast Neoplasms (Breast Cancer)
01/2021 - 03/2014
7Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 01/2015
7Nasal Polyps (Nasal Polyp)
05/2022 - 01/2011
7Rhinosinusitis
03/2022 - 01/2011
7Pain (Aches)
10/2020 - 02/2014
6Wounds and Injuries (Trauma)
11/2022 - 11/2012
6Lung Neoplasms (Lung Cancer)
10/2022 - 09/2013
6Dyslipidemias (Dyslipidemia)
01/2022 - 08/2012
6Carcinoma (Carcinomatosis)
01/2022 - 02/2007
6Albuminuria
12/2021 - 06/2012
6Diabetes Mellitus
11/2021 - 06/2006
6Carcinogenesis
07/2021 - 11/2009
5Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2017
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 02/2017
5Retinal Detachment (Retinal Detachments)
01/2022 - 01/2017
5Disease Progression
09/2021 - 01/2017
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 11/2014
4Fatty Liver
11/2021 - 10/2015

Drug/Important Bio-Agent (IBA)

34Glucose (Dextrose)FDA LinkGeneric
10/2022 - 04/2011
22Biomarkers (Surrogate Marker)IBA
10/2022 - 09/2013
22Proteins (Proteins, Gene)FDA Link
05/2022 - 06/2006
15LipidsIBA
10/2022 - 08/2012
15CytokinesIBA
03/2022 - 10/2002
13Pharmaceutical PreparationsIBA
06/2022 - 08/2012
13EnzymesIBA
03/2022 - 03/2011
13AlbuminsIBA
01/2022 - 06/2012
12Messenger RNA (mRNA)IBA
01/2022 - 12/2007
12CholesterolIBA
01/2022 - 03/2011
12Hemoglobins (Hemoglobin)IBA
01/2022 - 09/2013
12Retinaldehyde (Retinal)IBA
01/2022 - 01/2016
11MicroRNAs (MicroRNA)IBA
04/2022 - 01/2013
11Triglycerides (Triacylglycerol)IBA
01/2022 - 05/2011
11RNA (Ribonucleic Acid)IBA
01/2022 - 12/2007
10HDL CholesterolIBA
01/2022 - 05/2012
10DNA (Deoxyribonucleic Acid)IBA
01/2022 - 03/2004
10CreatinineIBA
01/2022 - 06/2012
10Biological ProductsIBA
01/2021 - 11/2009
9Insulin (Novolin)FDA Link
01/2022 - 04/2011
9Blood Glucose (Blood Sugar)IBA
10/2021 - 05/2011
9Ranibizumab (Lucentis)FDA Link
09/2021 - 01/2016
8Interleukin-6 (Interleukin 6)IBA
05/2022 - 03/2009
8ORALIT (ORS)IBA
01/2021 - 03/2014
7AllergensIBA
01/2022 - 10/2002
7LDL CholesterolIBA
01/2022 - 05/2012
7Cisplatin (Platino)FDA LinkGeneric
01/2019 - 02/2012
7bisphenol AIBA
01/2019 - 09/2011
6Indicators and Reagents (Reagents)IBA
10/2022 - 01/2012
6Immunoglobulin E (IgE)IBA
09/2022 - 04/2011
6Therapeutic UsesIBA
05/2022 - 12/2005
6Cadherins (E-Cadherin)IBA
04/2022 - 02/2007
6Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 01/2019
6Uric Acid (Urate)IBA
09/2021 - 08/2011
6Oxygen (Dioxygen)IBA
01/2021 - 12/2015
6Long Noncoding RNAIBA
01/2021 - 01/2018
6Circular RNAIBA
01/2020 - 01/2017
5AntioxidantsIBA
05/2022 - 01/2017
5Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
5Peptides (Polypeptides)IBA
01/2022 - 08/2017
5Hypoglycemic Agents (Hypoglycemics)IBA
11/2021 - 08/2011
5Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
11/2021 - 02/2013
5C-Reactive ProteinIBA
04/2021 - 04/2011
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 03/2010
5alpha-2-HS-GlycoproteinIBA
06/2017 - 04/2011
4HydrogelsIBA
11/2022 - 11/2012
4Bile Acids and Salts (Bile Acids)IBA
03/2022 - 01/2013
4SteroidsIBA
01/2022 - 01/2013
4oxidized low density lipoproteinIBA
01/2022 - 05/2012
4Capsules (Microcapsules)IBA
01/2022 - 05/2009
4ApolipoproteinsIBA
01/2022 - 01/2013

Therapy/Procedure

42Therapeutics
10/2022 - 06/2003
16Drug Therapy (Chemotherapy)
01/2022 - 08/2012
8Lasers (Laser)
01/2022 - 01/2016
7Radiotherapy
04/2022 - 01/2012
7Immunotherapy
01/2022 - 02/2016
6Glycemic Control
11/2021 - 08/2011
4Kidney Transplantation
01/2022 - 01/2021
4Vitrectomy
01/2022 - 01/2017